-
Discovery of new more infectious HIV variant A new variant of HIV has been discovered that causes more rapid onset of the disease. The new HIV strain was discovered in more than 100 people using data from the Netherlands. https://www.amsterdamumc.org/en/spotlight/discovery-of-new-more-infectious-hiv-variant.htm
-
Marc van der Valk appointed as president of Stichting HIV Monitoring Marc van der Valk (internist-infectiologist and head of the HIV Outpatient Clinic) will become the president of Stichting HIV Monitoring (SHM) as of 1 April 2021. He is succeeding Peter Reiss (Professor of Internal Medicine) who is retiring after eight years as director of SHM. https://www.amsterdamumc.org/en/research/institutes/amsterdam-institute-for-infection-and-immunity/news/marc-van-der-valk-appointed-as-president-of-stichting-hiv-monitoring.htm
-
AGEhIV cohort study The AGEhIV Cohort Study assesses aging and ageing-related diseases in people living with and without HIV. https://www.amsterdamumc.org/en/research/institutes/amsterdam-public-health/strengths/aph-cohorts/agehiv-cohort-study.htm
-
A good vaccine against HIV comes in threes Development of a vaccine against HIV is a real feat. Rogier Sanders, professor of Virology, in particular Experimental Vaccinology, has been working on a shot like this for years. https://www.amsterdamumc.org/en/spotlight/a-good-vaccine-against-hiv-comes-in-threes.htm
-
Uitgedokterd: illustrative podcast about 40 years of hiv in the Netherlands Amsterdam institute for Infection and Immunity researchers Marc van der Valk and Peter Reiss guide you through the world of hiv in this illustrative podcast by BNR. https://www.amsterdamumc.org/en/research/institutes/amsterdam-institute-for-infection-and-immunity/news/uitgedokterd-illustrative-podcast-about-40-years-of-hiv-in-the-netherlands.htm
-
Improved survival by screening for anal cancer precursors in people with HIV Researchers from Amsterdam UMC and Radboud UMC discovered that people living with HIV that were screened for anal cancer precursors were more likely to be diagnosed with anal cancer. This diagnosis occured at an earlier disease stage than unscreened individuals, resulting in better survival. https://www.amsterdamumc.org/en/research/institutes/amsterdam-institute-for-infection-and-immunity/news/improved-survival-by-screening-for-anal-cancer-precursors-in-people-with-hiv.htm
-
The Netherlands on its way to zero new HIV infections Internist/infectiologist Marc van der Valk sees a sharp drop in recent HIV infections among men who have sex with men, indicating a good effect of the HIV prevention pill (PrEP). https://www.amsterdamumc.org/en/research/institutes/amsterdam-institute-for-infection-and-immunity/news/the-netherlands-on-its-way-to-zero-new-hiv-infections.htm
-
COVID-19 progression in people with HIV AGEhiV cohort study expanded their research to map how COVID-19 progresses in people with HIV compared to HIV-negative controls. https://www.amsterdamumc.org/en/research/institutes/amsterdam-public-health/covid-19-initiatives/covid-19-progression-in-people-with-hiv-.htm
-
Discovery of new more infectious HIV variant A new variant of HIV has been discovered that causes more rapid onset of the disease. The new HIV strain was discovered in more than 100 people using data from the Netherlands. https://www.amsterdamumc.org/en/research/institutes/amsterdam-institute-for-infection-and-immunity/news/discovery-of-new-more-infectious-hiv-variant-1.htm
-
A good vaccine against HIV comes in threes Development of a vaccine against HIV is a real feat. Rogier Sanders, has been working on a shot like this for years. “We now know that one vaccine is not enough. That is why we are working on three different types of vaccines that together should provide sufficient protection.” https://www.amsterdamumc.org/en/research/institutes/amsterdam-institute-for-infection-and-immunity/news/a-good-vaccine-against-hiv-comes-in-threes-1.htm
236 Results found